Editors: Atta-ur-Rahman , Muhammad Iqbal Choudhary

Frontiers in Anti-infective Drug Discovery

Volume 9

eBook: US $89 Special Offer (PDF + Printed Copy): US $151
Printed Copy: US $107
Library License: US $356
ISBN: 978-1-68108-830-3 (Print)
ISBN: 978-1-68108-829-7 (Online)
Year of Publication: 2021
DOI: 10.2174/97816810882971210901

Introduction

This book series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the book series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships.

Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field.

The ninth volume of this series features 5 reviews that cover some aspects of clinical and pre-clinical antimicrobial drug development, with 2 chapters focusing on drugs to treat leishmaniasis and dengue fever, respectively.

- Use of preclinical and early clinical data for accelerating antimicrobial drug development

- Post-translational modifications: host defence mechanism, pathogenic weapon, and emerged target of anti-infective drugs

- Scope and limitations on the potent antimicrobial activities of hydrazone derivatives

- Current scenario of anti-leishmanial drugs and treatment

- Dengue hemorrhagic fever: the potential repurposing drugs

Contributors

Editor(s):
Prof. Atta-ur-Rahman FRS


Prof. Muhammad Iqbal Choudhary




Contributor(s):
Amarnath Sharma
Clinical Pharmacology and Pharmacometrics
Janssen Research & Development LLC
New Jersey
USA


Amit Roy
Department of Biotechnology
Savitribai Phule Pune University
Ganeshkhind Road, Pune-411007
India


Anastasia Tomatsidou
Howard Taylor Ricketts Laboratory
Argonne National Laboratory
Lemont, Illinois
USA
/
Department of Microbiology
University of Chicago
Chicago, Illinois
USA


Dimitra Paliogianni
Institute of Molecular Cell and Systems Biology
College of Medical, Veterinary & Life Sciences, University of Glasgow
Glasgow G12 8QQ
USA


Jean Michel Brunel
Aix Marseille University
INSERM, SSA, MCT
Marseille
France


Mahesh N. Samtani
Clinical Pharmacology and Pharmacometrics
Janssen Research & Development LLC
New Jersey
USA


Maria Amprazi
Institute of Molecular Biology and Biotechnology
Foundation of Research and Technology-Hellas
Heraklion, Crete
Greece
/
Department of Biology
University of Crete
Heraklion, Crete
Greece


Pathomthep Leowattana
Tivanon Medical Clinics
99 Tivanon Road, Muang
Nonthaburi 11000, Thailand


Priyanka H. Mazire
Department of Biotechnology
Savitribai Phule Pune University
Ganeshkhind Road, Pune-411007
India


Tawithep Leowattana
Department of Medicine
Faculty of Medicine
Srinakharinwirot University, 114 Sukhumvit 23, Wattana District, Bangkok 10110
Thailand


Vasiliki E. Fadouloglou
Department of Molecular Biology and Genetics
Democritus University of Thrace
Dragana University Campus, Alexandroupolis 68100, Evros
Greece


Wattana Leowattana
Department of Clinical Tropical Medicine
Faculty of Tropical Medicine
Mahidol University, 420/6 Rajavithi road, Rachatawee, Bangkok 10400
Thailand




RELATED BOOKS

.Frontiers in Drug Design and Discovery.
.In Silico and In vitro Approaches to Screen the Anti-TB Activity of Benzothiazole Analogs.
.Anti-Obesity Drug Discovery and Development.